Why Beach, Bendigo and Adelaide Bank, Opthea, and Paradigm shares are sinking

These ASX shares are having a bad start to the week…

| More on:
Close up of a sad young woman reading about declining share price on her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.6% to 7,072.6 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are dropping:

Beach Energy Ltd (ASX: BPT)

The Beach share price is down 12% to $1.63. Investors have been selling this energy producer's shares after its FY 2022 profits fell well short of expectations. Beach reported an underlying net profit after tax of $504 million. While this was up 39% year over year, it was nowhere near the consensus estimate of ~$546 million.

Bendigo and Adelaide Bank Ltd (ASX: BEN)

The Bendigo and Adelaide Bank share price is down over 8% to $9.89. This follows the release of the regional bank's FY 2022 results. Although the bank delivered a full year profit that was largely in line with expectations, its net interest margin (NIM) commentary appears to have disappointed investors. Goldman Sachs notes that "today's (NIM) update is disappointing."

Opthea Ltd (ASX: OPT)

The Opthea share price is down 9% to $1.27. This morning this clinical stage biopharmaceutical company announced that it has received binding commitments for a US$90 million placement to institutional investors. These funds were raised at a 17% discount of $1.15 per new share. The proceeds will be used to support phase 3 clinical trials of OPT-302.

Paradigm Biopharmaceuticals Ltd (ASX: PAR)

The Paradigm share price has crashed 27% lower to $1.45. This was also driven by a capital raising. The biopharmaceutical company is raising $66 million at $1.30 per new share. This represents a huge discount of 34.5% to the company's last close price of $1.985. Some of the proceeds will be used for Paradigm's phase 3 clinical program and new drug application-related activities.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo and Adelaide Bank Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Capstone Copper, Dateline, DroneShield, and Lindian shares are falling today

These shares are ending the week in the red. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why Fortescue, Generation Development, Northern Star, and Pantoro shares are falling today

These shares are missing out on the good times on Thursday. What's happening?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why 4DMedical, ARB, Inghams, and Qoria shares are tumbling today

These shares are under pressure on Tuesday. What's going on?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Fortescue, Life360, PLS, and Syrah shares are dropping today

These shares are starting the week in the red. But why?

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why Australian Ethical, Northern Minerals, PLS, and Woodside shares are falling today

These shares are ending the week in the red. But why?

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why 4DMedical, Amaero, Clarity Pharmaceuticals, and Treasury Wine shares are falling today

These shares are having a poor session. What's going on?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why EOS, Humm, Pantoro Gold, and Robex shares are dropping today

These shares are having a tough time on hump day. But why?

Read more »